A new trading day began on Tuesday, with Revolution Medicines Inc (NASDAQ: RVMD) stock price up 3.25% from the previous day of trading, before settling in for the closing price of $37.18. RVMD’s price has ranged from $29.17 to $62.40 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -27.80% over the past five years. Meanwhile, its annual earnings per share averaged -31.12%. With a float of $161.88 million, this company’s outstanding shares have now reached $186.26 million.
Let’s look at the performance matrix of the company that is accounted for 534 employees. In terms of profitability, gross margin is 45.12%, operating margin of -301.78%, and the pretax margin is -266.93%.
Revolution Medicines Inc (RVMD) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Revolution Medicines Inc is 13.09%, while institutional ownership is 93.78%. The most recent insider transaction that took place on Jun 20 ’25, was worth 75,736. In this transaction General Counsel of this company sold 1,912 shares at a rate of $39.61, taking the stock ownership to the 54,093 shares. Before that another transaction happened on Jun 20 ’25, when Company’s Officer proposed sale 1,912 for $39.93, making the entire transaction worth $76,346.
Revolution Medicines Inc (RVMD) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -31.12% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -8.09% during the next five years compared to -27.80% drop over the previous five years of trading.
Revolution Medicines Inc (NASDAQ: RVMD) Trading Performance Indicators
Here are Revolution Medicines Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 13.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.00, a number that is poised to hit -1.12 in the next quarter and is forecasted to reach -5.01 in one year’s time.
Technical Analysis of Revolution Medicines Inc (RVMD)
Revolution Medicines Inc (NASDAQ: RVMD) saw its 5-day average volume 1.36 million, a negative change from its year-to-date volume of 1.84 million. As of the previous 9 days, the stock’s Stochastic %D was 45.33%.
During the past 100 days, Revolution Medicines Inc’s (RVMD) raw stochastic average was set at 63.59%, which indicates a significant decrease from 64.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.25 in the past 14 days, which was lower than the 1.60 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $38.62, while its 200-day Moving Average is $42.30.
